Rockwell Medical Inc./$RMTI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Ticker
$RMTI
Sector
Primary listing
Employees
157
Headquarters
Website
RMTI Metrics
BasicAdvanced
$36M
-
-$0.15
1.71
-
Price and volume
Market cap
$36M
Beta
1.71
52-week high
$2.10
52-week low
$0.78
Average daily volume
267K
Financial strength
Current ratio
3.984
Quick ratio
3.459
Long term debt to equity
28.62
Total debt to equity
33.725
Interest coverage (TTM)
-4.17%
Profitability
EBITDA (TTM)
-2.499
Gross margin (TTM)
16.89%
Net profit margin (TTM)
-7.67%
Operating margin (TTM)
-6.77%
Revenue per employee (TTM)
$440,000
Management effectiveness
Return on assets (TTM)
-5.04%
Return on equity (TTM)
-15.28%
Valuation
Price to revenue (TTM)
0.473
Price to book
0.97
Price to tangible book (TTM)
1.36
Price to free cash flow (TTM)
-27.252
Free cash flow yield (TTM)
-3.67%
Free cash flow per share (TTM)
-0.033
Growth
Revenue change (TTM)
-31.76%
Earnings per share change (TTM)
503.58%
3-year revenue growth (CAGR)
-1.65%
10-year revenue growth (CAGR)
2.27%
3-year earnings per share growth (CAGR)
-51.18%
10-year earnings per share growth (CAGR)
-26.24%
RMTI News
AllArticlesVideos
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
Business Wire·3 days ago
Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results
Business Wire·2 weeks ago
Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Rockwell Medical Inc. stock?
Rockwell Medical Inc. (RMTI) has a market cap of $36M as of April 12, 2026.
What is the P/E ratio for Rockwell Medical Inc. stock?
The price to earnings (P/E) ratio for Rockwell Medical Inc. (RMTI) stock is 0 as of April 12, 2026.
Does Rockwell Medical Inc. stock pay dividends?
No, Rockwell Medical Inc. (RMTI) stock does not pay dividends to its shareholders as of April 12, 2026.
When is the next Rockwell Medical Inc. dividend payment date?
Rockwell Medical Inc. (RMTI) stock does not pay dividends to its shareholders.
What is the beta indicator for Rockwell Medical Inc.?
Rockwell Medical Inc. (RMTI) has a beta rating of 1.71. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.